TherapeuticsMD TXMD
NASDAQ TXMD
$1.90 +0.02 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) EBT Margin (2011 - 2026)

Updated

TherapeuticsMD (TXMD) reported EBT Margin of 18.87% for Q2 2026, down 38.38 percentage points from 57.25% a year earlier but up 4.65 percentage points from the prior quarter.

Analysis

TherapeuticsMD (TXMD) EBT Margin (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, TherapeuticsMD's EBT Margin came in at -8.04%, up 15.68 percentage points year-over-year; for FY2025, it came in at -21.61%, up 111.44 percentage points from FY2024.

  • EBT Margin has a five-year change of +261.29 percentage points (FY2020 to FY2025).
  • By year, EBT Margin came in at -133.05% in FY2024 (+461.57 pp), -594.62% in FY2023 (-596.16 pp), 1.54% in FY2022 (+3083.73 pp) and -3082.20% in FY2021 (-2799.30 pp).
  • Five-year quarterly EBT Margin spans a low of -4273.85% in Q2 2022 and a high of 268.50% in Q4 2021.
  • Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +462.86 percentage points.
  • The high point for year-over-year EBT Margin in five years was Q2 2023 (a gain of 3721.45 percentage points); the low point was Q2 2022 (a drop of 4088.42 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 14.23% (Q1 2026), -64.95% (Q4 2025) and 6.38% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 26.66%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 25.18%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 18.19%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -131.41%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -4.34%
10 TherapeuticsMD 21.67 Mn 21.67 Mn - 18.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.87%
Mar 31, 2026 14.23%
Dec 31, 2025 -64.95%
Sep 30, 2025 6.38%
Jun 30, 2025 57.25%
Mar 31, 2025 -169.97%
Dec 31, 2024 12.44%
Sep 30, 2024 -103.66%
Jun 30, 2024 -448.72%
Mar 31, 2024 -258.47%
Dec 31, 2023 -315.54%
Sep 30, 2023 -2,705.66%
Jun 30, 2023 -552.40%
Mar 31, 2023 -555.29%
Dec 31, 2022 70.67%
Sep 30, 2022 -4,133.05%
Jun 30, 2022 -4,273.85%
Mar 31, 2022 -2,571.94%
Dec 31, 2021 268.50%
Sep 30, 2021 -186.65%
API Access

TherapeuticsMD EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY